Samsung BioLogics

Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement
Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement
Fierce Pharma
Samsung BioLogics
Bristol Myers Squibb
drug manufacturing
antibodies
Flag link:
Pfizer Inks Manufacturing Deals with Samsung Biologics Worth Nearly $900M
Pfizer Inks Manufacturing Deals with Samsung Biologics Worth Nearly $900M
BioSpace
Pfizer
Samsung BioLogics
drug manufacturing
biosimilars
Flag link:
Samsung Biologics, Pfizer partner for biosimilars portfolio manufacturing
Samsung Biologics, Pfizer partner for biosimilars portfolio manufacturing
Pharmaceutical Business Review
Samsung BioLogics
Pfizer
biosimilars
Flag link:
Samsung Biologics spells out expansion plans in South Korea and US
Samsung Biologics spells out expansion plans in South Korea and US
Endpoints
Samsung BioLogics
South Korea
CDMOs
Flag link:
Samsung Biologics on track to open ‘super plant’ in October
Samsung Biologics on track to open ‘super plant’ in October
Biopharma Reporter
Samsung BioLogics
drug manufacturing
Super Plant
Flag link:
Samsung Biologics signs 426 bln-won land purchase deal to build 2nd campus
Samsung Biologics signs 426 bln-won land purchase deal to build 2nd campus
Yonhap News Agency
Samsung BioLogics
South Korea
CDMOs
Flag link:
Amidst large investment from parent company, Samsung Biologics seeks to ramp up biotech funding
Amidst large investment from parent company, Samsung Biologics seeks to ramp up biotech funding
Endpoints
Samsung BioLogics
funding
Flag link:
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand
Fierce Pharma
GSK
Vir Biotechnology
COVID-19
antibodies
drug manufacturing
Samsung BioLogics
Flag link:
To buy or not to buy? Samsung unit denies report about Biogen talks
To buy or not to buy? Samsung unit denies report about Biogen talks
Fierce Pharma
Biogen
Samsung BioLogics
M&A
Flag link:
Samsung Biologics to help Enzolytics advance clinical development of mAbs
Samsung Biologics to help Enzolytics advance clinical development of mAbs
Biopharma Reporter
Samsung BioLogics
Enzolytics
CDMOs
monoclonal antibodies
Flag link:
Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and more
Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and more
Fierce Pharma
Samsung BioLogics
CDMOs
hirings
drug manufacturing
Flag link:
Samsung Biologics to provide end-to-end mRNA vaccine manufacturing
Samsung Biologics to provide end-to-end mRNA vaccine manufacturing
Biopharma Reporter
Samsung BioLogics
MRNA
vaccines
COVID-19
South Korea
drug manufacturing
Flag link:
Moderna taps Samsung for fill-finish duties on 'hundreds of millions' of COVID-19 vaccine doses
Moderna taps Samsung for fill-finish duties on 'hundreds of millions' of COVID-19 vaccine doses
Fierce Pharma
Moderna Therapeutics
Samsung BioLogics
vaccines
COVID-19
Flag link:
Samsung BioLogics says decision pending on making Moderna vaccine as report ignites share
Samsung BioLogics says decision pending on making Moderna vaccine as report ignites share
Yahoo/Reuters
Samsung BioLogics
Moderna Therapeutics
COVID-19
vaccines
South Korea
contract drug manufacturing
Flag link:
Samsung Biologics and TG Therapeutics expand blood cancer partnership
Samsung Biologics and TG Therapeutics expand blood cancer partnership
Biopharma Reporter
TG Therapeutics
Samsung BioLogics
ublituximab
monoclonal antibodies
Flag link:
Samsung eyes manufacturing expansions into U.S. and beyond as work on Korean 'Super Plant' plows ahead
Samsung eyes manufacturing expansions into U.S. and beyond as work on Korean 'Super Plant' plows ahead
Fierce Pharma
Samsung BioLogics
South Korea
drug manufacturing
Super Plant
Flag link:
A Bright Day for Two Companies as New CEOs Announced
A Bright Day for Two Companies as New CEOs Announced
BioSpace
Pharma CEOs
SAGE Therapeutics
Samsung BioLogics
Flag link:
Samsung Biologics, AstraZeneca to dissolve biosimilar JV, scrap Rituxan copy program: report
Samsung Biologics, AstraZeneca to dissolve biosimilar JV, scrap Rituxan copy program: report
Fierce Pharma
Samsung BioLogics
AstraZeneca
Rituxan
Roche
biosimilars
Archigen Biotech
Flag link:
Samsung Biologics Teams Up with AstraZeneca to Propel Commercial Manufacturing
Samsung Biologics Teams Up with AstraZeneca to Propel Commercial Manufacturing
BioSpace
AstraZeneca
Samsung BioLogics
drug manufacturing
Flag link:
Samsung Biologics and AstraZeneca launch strategic manufacturing partnership
Samsung Biologics and AstraZeneca launch strategic manufacturing partnership
Biopharma Reporter
Samsung BioLogics
AstraZeneca
Asia
biologics
drug manufacturing
Flag link:

Pages